Report Detail

Pharma & Healthcare Global (United States, European Union and China) Amlodipine Besylate Market Research Report 2019-2025

  • RnM3703971
  • |
  • 28 August, 2019
  • |
  • Global
  • |
  • 127 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Amlodipine Besylate is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: Hypertension and Coronary Artery Disease.
In 2019, the market size of Amlodipine Besylate is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Amlodipine Besylate.

This report studies the global market size of Amlodipine Besylate, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Amlodipine Besylate sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Pfizer
Mylan
Dr. Reddy's Laboratories
Apotex
Teva Pharmaceutical
Cipla
Hikma Pharmaceuticals
Strides Pharma
Upsher-Smith Laboratories
InvaGen Pharmaceuticals
Sun Pharmaceutical
Aurobindo Pharma
Lupin Pharmaceuticals
Zydus Pharmaceuticals
Oxford Pharm
Wockhardt
Epic Pharma
CR Pharmaceutical
Alkem Laboratories
MACLEODS

Market Segment by Product Type
2.5mg Tablets
5mg Tablets
10mg Tablets

Market Segment by Application
High Blood Pressure
Heart Disease

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Amlodipine Besylate status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Amlodipine Besylate manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Amlodipine Besylate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Amlodipine Besylate Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 2.5mg Tablets
      • 1.3.3 5mg Tablets
      • 1.3.4 10mg Tablets
    • 1.4 Market Segment by Application
      • 1.4.1 Global Amlodipine Besylate Market Share by Application (2019-2025)
      • 1.4.2 High Blood Pressure
      • 1.4.3 Heart Disease
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Amlodipine Besylate Market Size
      • 2.1.1 Global Amlodipine Besylate Revenue 2014-2025
      • 2.1.2 Global Amlodipine Besylate Sales 2014-2025
    • 2.2 Amlodipine Besylate Growth Rate by Regions
      • 2.2.1 Global Amlodipine Besylate Sales by Regions 2014-2019
      • 2.2.2 Global Amlodipine Besylate Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Amlodipine Besylate Sales by Manufacturers
      • 3.1.1 Amlodipine Besylate Sales by Manufacturers 2014-2019
      • 3.1.2 Amlodipine Besylate Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Amlodipine Besylate Revenue by Manufacturers (2014-2019)
      • 3.2.2 Amlodipine Besylate Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Amlodipine Besylate Market Concentration Ratio (CR5 and HHI)
    • 3.3 Amlodipine Besylate Price by Manufacturers
    • 3.4 Key Manufacturers Amlodipine Besylate Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Amlodipine Besylate Market
    • 3.6 Key Manufacturers Amlodipine Besylate Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 2.5mg Tablets Sales and Revenue (2014-2019)
      • 4.1.2 5mg Tablets Sales and Revenue (2014-2019)
      • 4.1.3 10mg Tablets Sales and Revenue (2014-2019)
    • 4.2 Global Amlodipine Besylate Sales Market Share by Type
    • 4.3 Global Amlodipine Besylate Revenue Market Share by Type
    • 4.4 Amlodipine Besylate Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Amlodipine Besylate Sales by Application

    6 United States

    • 6.1 United States Amlodipine Besylate Breakdown Data by Company
    • 6.2 United States Amlodipine Besylate Breakdown Data by Type
    • 6.3 United States Amlodipine Besylate Breakdown Data by Application

    7 European Union

    • 7.1 European Union Amlodipine Besylate Breakdown Data by Company
    • 7.2 European Union Amlodipine Besylate Breakdown Data by Type
    • 7.3 European Union Amlodipine Besylate Breakdown Data by Application

    8 China

    • 8.1 China Amlodipine Besylate Breakdown Data by Company
    • 8.2 China Amlodipine Besylate Breakdown Data by Type
    • 8.3 China Amlodipine Besylate Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Amlodipine Besylate Breakdown Data by Company
    • 9.2 Rest of World Amlodipine Besylate Breakdown Data by Type
    • 9.3 Rest of World Amlodipine Besylate Breakdown Data by Application
    • 9.4 Rest of World Amlodipine Besylate Breakdown Data by Countries
      • 9.4.1 Rest of World Amlodipine Besylate Sales by Countries
      • 9.4.2 Rest of World Amlodipine Besylate Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Pfizer
      • 10.1.1 Pfizer Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Amlodipine Besylate
      • 10.1.4 Amlodipine Besylate Product Introduction
      • 10.1.5 Pfizer Recent Development
    • 10.2 Mylan
      • 10.2.1 Mylan Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Amlodipine Besylate
      • 10.2.4 Amlodipine Besylate Product Introduction
      • 10.2.5 Mylan Recent Development
    • 10.3 Dr. Reddy's Laboratories
      • 10.3.1 Dr. Reddy's Laboratories Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Amlodipine Besylate
      • 10.3.4 Amlodipine Besylate Product Introduction
      • 10.3.5 Dr. Reddy's Laboratories Recent Development
    • 10.4 Apotex
      • 10.4.1 Apotex Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Amlodipine Besylate
      • 10.4.4 Amlodipine Besylate Product Introduction
      • 10.4.5 Apotex Recent Development
    • 10.5 Teva Pharmaceutical
      • 10.5.1 Teva Pharmaceutical Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Amlodipine Besylate
      • 10.5.4 Amlodipine Besylate Product Introduction
      • 10.5.5 Teva Pharmaceutical Recent Development
    • 10.6 Cipla
      • 10.6.1 Cipla Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Amlodipine Besylate
      • 10.6.4 Amlodipine Besylate Product Introduction
      • 10.6.5 Cipla Recent Development
    • 10.7 Hikma Pharmaceuticals
      • 10.7.1 Hikma Pharmaceuticals Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Amlodipine Besylate
      • 10.7.4 Amlodipine Besylate Product Introduction
      • 10.7.5 Hikma Pharmaceuticals Recent Development
    • 10.8 Strides Pharma
      • 10.8.1 Strides Pharma Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Amlodipine Besylate
      • 10.8.4 Amlodipine Besylate Product Introduction
      • 10.8.5 Strides Pharma Recent Development
    • 10.9 Upsher-Smith Laboratories
      • 10.9.1 Upsher-Smith Laboratories Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Amlodipine Besylate
      • 10.9.4 Amlodipine Besylate Product Introduction
      • 10.9.5 Upsher-Smith Laboratories Recent Development
    • 10.10 InvaGen Pharmaceuticals
      • 10.10.1 InvaGen Pharmaceuticals Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Amlodipine Besylate
      • 10.10.4 Amlodipine Besylate Product Introduction
      • 10.10.5 InvaGen Pharmaceuticals Recent Development
    • 10.11 Sun Pharmaceutical
    • 10.12 Aurobindo Pharma
    • 10.13 Lupin Pharmaceuticals
    • 10.14 Zydus Pharmaceuticals
    • 10.15 Oxford Pharm
    • 10.16 Wockhardt
    • 10.17 Epic Pharma
    • 10.18 CR Pharmaceutical
    • 10.19 Alkem Laboratories
    • 10.20 MACLEODS

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Amlodipine Besylate Sales Channels
      • 11.2.2 Amlodipine Besylate Distributors
    • 11.3 Amlodipine Besylate Customers

    12 Market Forecast

    • 12.1 Global Amlodipine Besylate Sales and Revenue Forecast 2019-2025
    • 12.2 Global Amlodipine Besylate Sales Forecast by Type
    • 12.3 Global Amlodipine Besylate Sales Forecast by Application
    • 12.4 Amlodipine Besylate Forecast by Regions
      • 12.4.1 Global Amlodipine Besylate Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Amlodipine Besylate Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Amlodipine Besylate. Industry analysis & Market Report on Amlodipine Besylate is a syndicated market report, published as Global (United States, European Union and China) Amlodipine Besylate Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Amlodipine Besylate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,535.44
      3,803.16
      5,070.88
      3,024.16
      4,536.24
      6,048.32
      501,052.80
      751,579.20
      1,002,105.60
      275,880.80
      413,821.20
      551,761.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report